Jennifer Nolley, APRN
Acute Care · Dallas, TXNPI 1306610829
Payments from drug & device makers
Across 101 payments — averaging $26.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$801
- AbbVie$311
- Johnson & Johnson$266
- Regeneron Healthcare Solutions, Inc.$221
- LEO Pharma Inc.$196
- Sanofi$162
- plus $742 from 14 others
What the payments were for
- Food & beverage$2,13979%
- Education$55821%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 23 | $801 |
| AbbVie | 16 | $311 |
| Johnson & Johnson | 4 | $266 |
| Regeneron Healthcare Solutions, Inc. | 6 | $221 |
| LEO Pharma Inc. | 7 | $196 |
| Sanofi | 10 | $162 |
| Pfizer | 8 | $154 |
| Novartis | 4 | $103 |
| Amgen | 5 | $98 |
| Botanix SB Inc | 3 | $62 |
| Kyowa Kirin, Inc. | 2 | $51 |
| UCB, Inc. | 2 | $51 |
| Mayne Pharma Commercial LLC | 2 | $49 |
| Lilly USA, LLC | 2 | $47 |
| Almirall LLC | 2 | $41 |
| Biofrontera Inc. | 1 | $23 |
| Arcutis Biotherapeutics, Inc. | 1 | $23 |
| Dermavant Sciences, Inc. | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Organon | 1 | $7 |
How this compares
$2,697 in reported general payments places this provider in the 85th percentile of 2,323 acute care providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 16 | $575 |
| Ketoconazole | 37 | $524 |
| Triamcinolone Acetonide | 41 | $336 |
| Doxycycline Hyclate | 13 | $163 |
| Mupirocin | 22 | $161 |
Paid to pharmacies, not to this prescriber.
Other acute care in Dallas
- Jennifer PilotteDallas$232K
- Amanda BradleyDallas$85K
- Martha LibertyDallas$28K
- Rachael SchneiderDallas$20K
- Peter TriporoDallas$15K
- Mario PadillaDallas$13K
- Toni SmithDallas$10K
- Christie MorrisonSan Antonio$225K
- Laura WilsonEl Paso$32K
- Kim HuynhCypress$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.